Mexico: COFEPRIS Issues Communication for Clinical Trials during COVID-19 Pandemic

April 30, 2020

On April 21, 2020, the Federal Commission for the Protection Against Sanitary Risks (Comisión Federal para la Protección contra Riesgos Sanitarios) (COFEPRIS)) issued a communication about ensuring the safety of clinical trial participants during the COVID-19 pandemic. In particular, each authorized protocol must have a risk mitigation plan for research participants that evaluates alternative safety methods for study monitoring. (Google translation of communication)